TransCatheter Replacement Of the Mitral Valve With the Novel Cephea Mitral Valve System

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 565 participants.

Also called NCT07798726

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 565 participants (planned count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07798726
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07798726. Non-randomized; no masking; primary purpose treatment. Start 2026-10-21 (actual); primary completion 2031-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TransCatheter Replacement Of the Mitral Valve With the Novel Cephea Mitral Valve System
Acronym
CROWN-MV
Condition
Mitral Valve Disease
Condition
Mitral Annulus Calcification
Condition
Mitral Regurgitation
Condition
Mitral Stenosis
Condition
Mitral Valve (MV) Regurgitation
Condition
Mitral Valve Replacement
Condition
Transcatheter Valve Replacement
Condition
Mitral Valve Insufficiency
Condition
Heart Valve Disease
Intervention (Device)
Cephea Mitral Valve System
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct07798726
Content hash
bdfcfde3b451f95d17a310cd050a74a21fb80fa31057b432578c41667046bda0